This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

This CTD dossier owner and manufacturer is a technology-driven enterprise with a focus on product quality and timely delivery. Its ultra-modern, WHO and GMP-certified manufacturing facility is located in a pollution-free industrial estate near major SEZ hubs in Asia. The company exports its products to Southeast Asia, Africa, the CIS region, Latin America & Central America, and the GCC. They supply prescription medications and likely over-the-counter drugs, as indicated by their global distribution network. They emphasize a "human approach" to business with trade partners and prioritize ethical production practices.